This study reveals that phillyrin inhibits CRC cell metastasis and induces apoptosis via the PI3K/AKT/mTOR pathway, highlighting its promise as a potential therapeutic candidate for future colorectal cancer treatment. The gene discussed is MTOR; the disease is colorectal carcinoma.